FGFR2 Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Innovent Biologics (Suzhou) Co. Ltd. (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadsystemic therapy

I am/have/hadnon-resectable cholangiocellular carcinoma

I am/have/hadnon-resectable cholangiocarcinoma

I am/have/hadmeasurable disease

I am/have/hadFGFR2

I am/have/hadcholangiocarcinoma

added new label for I am/have/had

more

I am looking for

I am looking forpemigatinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement

This is a phase 2 study to investigate the efficacy and safety of Pemigatinib in treating patients with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 rearrangement who have failed at least 1 previous therapy

systemic therapy

non-resectable cholangiocellular carcinoma

pemigatinib

non-resectable cholangiocarcinoma

measurable disease

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.